Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes (2022)
Attributed to:
MICA: Health e-Research Centre
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/figshare.18286751.v1
Publication URI: http://dx.doi.org/10.2337/figshare.18286751.v1
Type: Other